{"id":19760,"date":"2023-09-04T11:40:38","date_gmt":"2023-09-04T09:40:38","guid":{"rendered":"https:\/\/ggba.swiss\/neurosoft-breaks-new-ground-with-it-pioneering-brain-interface-technology\/"},"modified":"2023-09-04T11:44:36","modified_gmt":"2023-09-04T09:44:36","slug":"neurosoft-innove-avec-sa-technologie-pionniere-dinterface-cerebrale","status":"publish","type":"post","link":"https:\/\/ggba.swiss\/fr\/neurosoft-innove-avec-sa-technologie-pionniere-dinterface-cerebrale\/","title":{"rendered":"Neurosoft innove avec sa technologie pionni\u00e8re d&rsquo;interface c\u00e9r\u00e9brale"},"content":{"rendered":"\n<p>Lors d&rsquo;un essai clinique dirig\u00e9 par le Professeur Nitin Tandon et r\u00e9alis\u00e9 \u00e0 Memorial Hermann \u00e0 Houston, les \u00e9lectrodes sous-durales de <a href=\"https:\/\/neurosoft-bio.com\/\">Neurosoft Bioelectronics<\/a> ont \u00e9t\u00e9 test\u00e9es pour la premi\u00e8re fois sur des sujets humains lors d&rsquo;une chirurgie de r\u00e9section de l&rsquo;\u00e9pilepsie. Cette technologie innovante a d\u00e9montr\u00e9 un potentiel remarquable, montrant sa capacit\u00e9 \u00e0 \u00eatre ins\u00e9r\u00e9e en toute s\u00e9curit\u00e9 dans des zones du cerveau o\u00f9 d&rsquo;autres implants n&rsquo;osent pas s&rsquo;aventurer. De ce fait, de nouveaux traitements pour des conditions comme le tinnitus s\u00e9v\u00e8re, qui n&rsquo;a actuellement pas de rem\u00e8de d\u00e9finitif, pourraient bient\u00f4t voir le jour.<\/p>\n\n\n\n<p>Qu&rsquo;est-ce qui distingue ces \u00e9lectrodes ? Leur conception complexe implique une densit\u00e9 d&rsquo;\u00e9lectrodes cinq fois sup\u00e9rieure \u00e0 celle des \u00e9lectrodes conventionnelles et une composition 1\u2019000 fois plus douce. Cela amplifie non seulement leur capacit\u00e9 diagnostique, mais r\u00e9duit \u00e9galement les effets secondaires li\u00e9s aux proc\u00e9dures invasives, tels que la compression c\u00e9r\u00e9brale, les h\u00e9matomes et la formation de cicatrices.<\/p>\n\n\n\n<p>Pour d\u00e9montrer sa prouesse diagnostique, pendant la proc\u00e9dure de r\u00e9section initiale, ces \u00e9lectrodes ont r\u00e9ussi \u00e0 capturer des motifs d&rsquo;activit\u00e9 c\u00e9r\u00e9brale distincts du cortex auditif et \u00e0 localiser les pointes interictales dans l&rsquo;hippocampe. Les implications de ceci sont vastes, car la technologie de Neurosoft pourrait r\u00e9volutionner l&rsquo;approche th\u00e9rapeutique de l&rsquo;\u00e9pilepsie et r\u00e9v\u00e9ler d&rsquo;autres biomarqueurs essentiels pour \u00e9laborer des traitements efficaces pour toute une gamme de troubles c\u00e9r\u00e9braux.<\/p>\n\n\n\n<p>Nicolas Vachicouras, CEO et co-fondateur de Neurosoft Bioelectronics, a d\u00e9clar\u00e9 : \u00ab&nbsp;La maturit\u00e9 de notre technologie a \u00e9t\u00e9 soulign\u00e9e par ses premiers tests sur l&rsquo;homme. \u00c0 chaque essai, nous nous rapprochons d&rsquo;aider potentiellement des millions de personnes.&nbsp;\u00bb<\/p>\n\n\n\n<p>Le Professeur Lacour, co-fondateur de l&rsquo;entreprise et Directeur de l&rsquo;<a href=\"https:\/\/neuro-x.epfl.ch\/en\/\">Institut Neuro-X<\/a> \u00e0 l&rsquo;EPFL, a soulign\u00e9 l&rsquo;importance de cette \u00e9tape, comblant le foss\u00e9 entre la recherche acad\u00e9mique et les applications cliniques concr\u00e8tes.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\">Transformer des visions ambitieuses en r\u00e9alit\u00e9s<\/h4>\n\n\n\n<p>Le <a href=\"https:\/\/www.campusbiotech.ch\/\">Campus Biotech<\/a> \u00e0 Gen\u00e8ve offre un terreau id\u00e9al pour les start-ups comme Neurosoft. Cet hub innovant, nich\u00e9 au c\u0153ur de la <a href=\"https:\/\/bioalps.org\/the-health-valley\/\">Health Valley<\/a>, propose une combinaison de comp\u00e9tences acad\u00e9miques, d&rsquo;installations de pointe et d&rsquo;un \u00e9cosyst\u00e8me entrepreneurial de soutien.<\/p>\n\n\n\n<p>La position unique de la Suisse occidentale, riche en institutions de renomm\u00e9e mondiale, en biotechnologies florissantes et \u00e0 proximit\u00e9 de g\u00e9ants acad\u00e9miques et industriels, garantit que les start-ups sont parfaitement \u00e9quip\u00e9es pour transformer leurs ambitieuses visions en r\u00e9alit\u00e9s.<\/p>\n\n\n\n<p>\u00c0 l&rsquo;avenir, Neurosoft se pr\u00e9pare pour des tests plus approfondis, esp\u00e9rant valider davantage la puissance de sa technologie, qui englobera une multitude d&rsquo;applications, allant du traitement du tinnitus et de la paralysie \u00e0 la contribution aux projets de recherche dans le monde entier.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Bas\u00e9e au Campus Biotech \u00e0 Gen\u00e8ve, Neurosoft Bioelectronics a r\u00e9alis\u00e9 avec succ\u00e8s un essai clinique r\u00e9volutionnaire de sa grille d&rsquo;\u00e9lectrodes extensibles \u00e0 haut canal, marquant une \u00e9tape vers la cr\u00e9ation d&rsquo;interfaces c\u00e9r\u00e9brales plus s\u00fbres et plus efficaces.<\/p>\n","protected":false},"author":6,"featured_media":19756,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"mc4wp_mailchimp_campaign":[],"footnotes":""},"categories":[843],"tags":[1181,1163,1141],"class_list":["post-19760","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sciences-de-la-vie","tag-medical-devices-fr","tag-medtech-fr-2","tag-personalized-medicine-fr-2"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Neurosoft innove avec sa technologie d&#039;interface c\u00e9r\u00e9brale | GGBa<\/title>\n<meta name=\"description\" content=\"Neurosoft Bioelectronics a r\u00e9alis\u00e9 avec succ\u00e8s un essai clinique r\u00e9volutionnaire de sa grille d&#039;\u00e9lectrodes extensibles.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ggba.swiss\/fr\/neurosoft-innove-avec-sa-technologie-pionniere-dinterface-cerebrale\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Neurosoft innove avec sa technologie d&#039;interface c\u00e9r\u00e9brale | GGBa\" \/>\n<meta property=\"og:description\" content=\"Neurosoft Bioelectronics a r\u00e9alis\u00e9 avec succ\u00e8s un essai clinique r\u00e9volutionnaire de sa grille d&#039;\u00e9lectrodes extensibles.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ggba.swiss\/fr\/neurosoft-innove-avec-sa-technologie-pionniere-dinterface-cerebrale\/\" \/>\n<meta property=\"og:site_name\" content=\"Greater Geneva Bern area\" \/>\n<meta property=\"article:published_time\" content=\"2023-09-04T09:40:38+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-09-04T09:44:36+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ggba.swiss\/app\/uploads\/2023\/09\/neurosoft_bioelectronics-1180x811-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1180\" \/>\n\t<meta property=\"og:image:height\" content=\"811\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Pierre-Yves Oehrli\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Pierre-Yves Oehrli\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ggba.swiss\/fr\/neurosoft-innove-avec-sa-technologie-pionniere-dinterface-cerebrale\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/neurosoft-innove-avec-sa-technologie-pionniere-dinterface-cerebrale\/\"},\"author\":{\"name\":\"Pierre-Yves Oehrli\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"headline\":\"Neurosoft innove avec sa technologie pionni\u00e8re d&rsquo;interface c\u00e9r\u00e9brale\",\"datePublished\":\"2023-09-04T09:40:38+00:00\",\"dateModified\":\"2023-09-04T09:44:36+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/neurosoft-innove-avec-sa-technologie-pionniere-dinterface-cerebrale\/\"},\"wordCount\":487,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/neurosoft-innove-avec-sa-technologie-pionniere-dinterface-cerebrale\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/09\/neurosoft_bioelectronics-1180x811-1.jpg\",\"keywords\":[\"Medical Devices\",\"Medtech\",\"Personalized Medicine\"],\"articleSection\":[\"Sciences de la vie\"],\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/ggba.swiss\/fr\/neurosoft-innove-avec-sa-technologie-pionniere-dinterface-cerebrale\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ggba.swiss\/fr\/neurosoft-innove-avec-sa-technologie-pionniere-dinterface-cerebrale\/\",\"url\":\"https:\/\/ggba.swiss\/fr\/neurosoft-innove-avec-sa-technologie-pionniere-dinterface-cerebrale\/\",\"name\":\"Neurosoft innove avec sa technologie d'interface c\u00e9r\u00e9brale | GGBa\",\"isPartOf\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/neurosoft-innove-avec-sa-technologie-pionniere-dinterface-cerebrale\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/neurosoft-innove-avec-sa-technologie-pionniere-dinterface-cerebrale\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/09\/neurosoft_bioelectronics-1180x811-1.jpg\",\"datePublished\":\"2023-09-04T09:40:38+00:00\",\"dateModified\":\"2023-09-04T09:44:36+00:00\",\"author\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"description\":\"Neurosoft Bioelectronics a r\u00e9alis\u00e9 avec succ\u00e8s un essai clinique r\u00e9volutionnaire de sa grille d'\u00e9lectrodes extensibles.\",\"breadcrumb\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/neurosoft-innove-avec-sa-technologie-pionniere-dinterface-cerebrale\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ggba.swiss\/fr\/neurosoft-innove-avec-sa-technologie-pionniere-dinterface-cerebrale\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ggba.swiss\/fr\/neurosoft-innove-avec-sa-technologie-pionniere-dinterface-cerebrale\/#primaryimage\",\"url\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/09\/neurosoft_bioelectronics-1180x811-1.jpg\",\"contentUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/09\/neurosoft_bioelectronics-1180x811-1.jpg\",\"width\":1180,\"height\":811,\"caption\":\"Les r\u00e9centes r\u00e9ussites de Neurosoft ouvrent la voie \u00e0 des m\u00e9thodes de traitement innovantes et \u00e0 des capacit\u00e9s diagnostiques accrues pour les troubles neurologiques graves. | \u00a9 Neurosoft Bioelectronics\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ggba.swiss\/fr\/neurosoft-innove-avec-sa-technologie-pionniere-dinterface-cerebrale\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ggba.swiss\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Neurosoft innove avec sa technologie pionni\u00e8re d&#8217;interface c\u00e9r\u00e9brale\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\",\"url\":\"https:\/\/staging.ggba.swiss\/en\/\",\"name\":\"Greater Geneva Bern area\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\",\"name\":\"Pierre-Yves Oehrli\",\"url\":\"https:\/\/ggba.swiss\/fr\/author\/pierre-yves-oehrli\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Neurosoft innove avec sa technologie d'interface c\u00e9r\u00e9brale | GGBa","description":"Neurosoft Bioelectronics a r\u00e9alis\u00e9 avec succ\u00e8s un essai clinique r\u00e9volutionnaire de sa grille d'\u00e9lectrodes extensibles.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ggba.swiss\/fr\/neurosoft-innove-avec-sa-technologie-pionniere-dinterface-cerebrale\/","og_locale":"fr_FR","og_type":"article","og_title":"Neurosoft innove avec sa technologie d'interface c\u00e9r\u00e9brale | GGBa","og_description":"Neurosoft Bioelectronics a r\u00e9alis\u00e9 avec succ\u00e8s un essai clinique r\u00e9volutionnaire de sa grille d'\u00e9lectrodes extensibles.","og_url":"https:\/\/ggba.swiss\/fr\/neurosoft-innove-avec-sa-technologie-pionniere-dinterface-cerebrale\/","og_site_name":"Greater Geneva Bern area","article_published_time":"2023-09-04T09:40:38+00:00","article_modified_time":"2023-09-04T09:44:36+00:00","og_image":[{"width":1180,"height":811,"url":"https:\/\/ggba.swiss\/app\/uploads\/2023\/09\/neurosoft_bioelectronics-1180x811-1.jpg","type":"image\/jpeg"}],"author":"Pierre-Yves Oehrli","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Pierre-Yves Oehrli","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ggba.swiss\/fr\/neurosoft-innove-avec-sa-technologie-pionniere-dinterface-cerebrale\/#article","isPartOf":{"@id":"https:\/\/ggba.swiss\/fr\/neurosoft-innove-avec-sa-technologie-pionniere-dinterface-cerebrale\/"},"author":{"name":"Pierre-Yves Oehrli","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"headline":"Neurosoft innove avec sa technologie pionni\u00e8re d&rsquo;interface c\u00e9r\u00e9brale","datePublished":"2023-09-04T09:40:38+00:00","dateModified":"2023-09-04T09:44:36+00:00","mainEntityOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/neurosoft-innove-avec-sa-technologie-pionniere-dinterface-cerebrale\/"},"wordCount":487,"commentCount":0,"image":{"@id":"https:\/\/ggba.swiss\/fr\/neurosoft-innove-avec-sa-technologie-pionniere-dinterface-cerebrale\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2023\/09\/neurosoft_bioelectronics-1180x811-1.jpg","keywords":["Medical Devices","Medtech","Personalized Medicine"],"articleSection":["Sciences de la vie"],"inLanguage":"fr-FR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/ggba.swiss\/fr\/neurosoft-innove-avec-sa-technologie-pionniere-dinterface-cerebrale\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/ggba.swiss\/fr\/neurosoft-innove-avec-sa-technologie-pionniere-dinterface-cerebrale\/","url":"https:\/\/ggba.swiss\/fr\/neurosoft-innove-avec-sa-technologie-pionniere-dinterface-cerebrale\/","name":"Neurosoft innove avec sa technologie d'interface c\u00e9r\u00e9brale | GGBa","isPartOf":{"@id":"https:\/\/staging.ggba.swiss\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/neurosoft-innove-avec-sa-technologie-pionniere-dinterface-cerebrale\/#primaryimage"},"image":{"@id":"https:\/\/ggba.swiss\/fr\/neurosoft-innove-avec-sa-technologie-pionniere-dinterface-cerebrale\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2023\/09\/neurosoft_bioelectronics-1180x811-1.jpg","datePublished":"2023-09-04T09:40:38+00:00","dateModified":"2023-09-04T09:44:36+00:00","author":{"@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"description":"Neurosoft Bioelectronics a r\u00e9alis\u00e9 avec succ\u00e8s un essai clinique r\u00e9volutionnaire de sa grille d'\u00e9lectrodes extensibles.","breadcrumb":{"@id":"https:\/\/ggba.swiss\/fr\/neurosoft-innove-avec-sa-technologie-pionniere-dinterface-cerebrale\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ggba.swiss\/fr\/neurosoft-innove-avec-sa-technologie-pionniere-dinterface-cerebrale\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ggba.swiss\/fr\/neurosoft-innove-avec-sa-technologie-pionniere-dinterface-cerebrale\/#primaryimage","url":"https:\/\/ggba.swiss\/app\/uploads\/2023\/09\/neurosoft_bioelectronics-1180x811-1.jpg","contentUrl":"https:\/\/ggba.swiss\/app\/uploads\/2023\/09\/neurosoft_bioelectronics-1180x811-1.jpg","width":1180,"height":811,"caption":"Les r\u00e9centes r\u00e9ussites de Neurosoft ouvrent la voie \u00e0 des m\u00e9thodes de traitement innovantes et \u00e0 des capacit\u00e9s diagnostiques accrues pour les troubles neurologiques graves. | \u00a9 Neurosoft Bioelectronics"},{"@type":"BreadcrumbList","@id":"https:\/\/ggba.swiss\/fr\/neurosoft-innove-avec-sa-technologie-pionniere-dinterface-cerebrale\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ggba.swiss\/fr\/"},{"@type":"ListItem","position":2,"name":"Neurosoft innove avec sa technologie pionni\u00e8re d&#8217;interface c\u00e9r\u00e9brale"}]},{"@type":"WebSite","@id":"https:\/\/staging.ggba.swiss\/en\/#website","url":"https:\/\/staging.ggba.swiss\/en\/","name":"Greater Geneva Bern area","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41","name":"Pierre-Yves Oehrli","url":"https:\/\/ggba.swiss\/fr\/author\/pierre-yves-oehrli\/"}]}},"_links":{"self":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/19760","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/comments?post=19760"}],"version-history":[{"count":1,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/19760\/revisions"}],"predecessor-version":[{"id":19762,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/19760\/revisions\/19762"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media\/19756"}],"wp:attachment":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media?parent=19760"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/categories?post=19760"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/tags?post=19760"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}